Skip to main content

Table 1 Baseline characteristics for extension study participants by response to interest in extended access question

From: Extending access to a web-based mental health intervention: who wants more, what happens to use over time, and is it helpful? Results of a concealed, randomized controlled extension study

Baseline Characteristic

Interest in Extended Access

 

Yes

n = 119

No

n = 114

P value

Recruitment site, n(%)

  

.73

 A (General Hospital)

56 (47)

57 (50)

 

 B (Provincial Mental Health Facility)

35 (29)

35 (31)

 

 C (Ambulatory Care Hospital)

28 (24)

22 (19)

 

RAS-R total score, mean (SD)

83.0 (13.6)

83.5 (16.2)

.80

PHQ-9 total score, mean (SD)

12.1 (6.3)

10.7 (6.5)

.11

GAD-7 total score, mean (SD)

9.8 (5.2)

8.3 (5.4)

.04*

CIQ total score, mean (SD)

13.7 (4.7)

13.9 (5.2)

.81

EQ VAS, mean (SD)

57.1 (22.3)

61.6 (19.8)

.11

Total number of BWW log-ins in first 3 months, median (Q1,Q3)

7 (2,18)

6 (3,13)

.44

Age [y], mean (SD)

42.2 (12.4)

42.7 (14.3)

.82

Gender, n(%)

  

.73

 Male

29 (24.4)

33 (28.9)

 

 Female

89 (74.8)

80 (70.2)

 

 Transgendered or other

1 (0.8)

1 (0.9)

 

Ethnicity, n(%)

  

.34

 White

98 (82.4)

99 (86.8)

 

 Non-white

21 (17.6)

15 (13.2)

 

Relationship Status, n(%)

  

.58

 In a relationship

69 (58.0)

62 (54.4)

 

 Not in a relationship

50 (42.0)

52 (45.6)

 

Employment Status, n(%)

  

.89

 Full-time (including homemaker with young children)

43 (36.1)

40 (35.0)

 

 Part-time/volunteer/homemaker without young children

18 (15.1)

20 (17.6)

 

 Not working

57 (47.9)

54 (47.4)

 

 Missing

1 (0.8)

0 (0.0)

 

Household income [$CAD], n(%)

  

.70

  < $35 K

47 (45.2)

38 (7.3)

 

 $35 K - $50 K

11 (9.2)

12 (10.5)

 

 $50 K - $80 K

20 (11.1)

21 (11.8)

 

  > $80 K

26 (26.5)

31 (31.6)

 

 Missing

15 (12.6)

12 (10.5)

 

Age [y] first experienced mental health problems, mean (SD)

18.7 (12.1)

18.8 (12.3)

.96

Age [y] first sought help, mean (SD)

25.9 (12.5)

27.2 (12.9)

.44

Taking psychotropic medication, n(%)

  

.97

 Yes

94 (79.0)

89 (78.1)

 

 No

25 (31.0)

24 (21.0)

 

 Missing

0 (0.0)

1 (0.9)

 
  1. Baseline represents the time point when extended access was offered. Percentages are column percentages and may not add exactly to 100.0% due to rounding. Statistical analyses exclude missing data
  2. SD standard deviation, Q1 first quartile, Q3 third quartile, CAD Canadian: RAS-r Recovery Assessment Scale – revised, PHQ-9 Patient Health Questionnaire – 9 item, GAD-7 Generalized Anxiety Disorder Questionnaire – 7 item, EQ-VAS EuroQOL Visual Analog Scale (out of 100), CIQ Community Integration Questionnaire
  3. *P < .05